Scott Andreas Tobler

Title: Scott Andreas Tobler: Innovator in Antigen Binding Molecules

Introduction

Scott Andreas Tobler is a notable inventor based in South Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the purification of single domain antigen binding molecules. With a total of 2 patents, Tobler's work is paving the way for advancements in medical and therapeutic applications.

Latest Patents

Tobler's latest patents focus on methods for the purification of single domain antigen binding molecules. These processes involve purifying or separating Single Domain Antigen Binding (SDAB) molecules, which include one or more single binding domains, such as nanobody molecules. His innovative techniques utilize Protein A-based affinity chromatography to achieve high purity levels, substantially devoid of a complementary antibody domain and an immunoglobulin constant region.

Career Highlights

Throughout his career, Tobler has been associated with Ablynx N.V., a company known for its pioneering work in biopharmaceuticals. His expertise in the purification processes has contributed to the development of novel therapeutic agents that can target specific diseases more effectively.

Collaborations

Some of his notable coworkers include Andrew M. Wood and Austin Wayne Boesch. Their collaborative efforts have further enhanced the research and development initiatives at Ablynx N.V.

Conclusion

Scott Andreas Tobler's innovative work in the field of antigen binding molecules exemplifies the impact of dedicated inventors in biotechnology. His contributions are essential for the advancement of therapeutic solutions in medicine.